121 related articles for article (PubMed ID: 36502636)
1. ZBTB20-AS1 promoted Alzheimer's disease progression through ZBTB20/GSK-3β/Tau pathway.
Wang Y; Cai M; Lou Y; Zhang S; Liu X
Biochem Biophys Res Commun; 2023 Jan; 640():88-96. PubMed ID: 36502636
[TBL] [Abstract][Full Text] [Related]
2. Knockdown of long non-coding RNA SOX21-AS1 attenuates amyloid-β-induced neuronal damage by sponging miR-107.
Xu W; Li K; Fan Q; Zong B; Han L
Biosci Rep; 2020 Mar; 40(3):. PubMed ID: 32124921
[TBL] [Abstract][Full Text] [Related]
3. The protective underlying mechanisms of Schisandrin on SH-SY5Y cell model of Alzheimer's disease.
Zhao ZY; Zhang YQ; Zhang YH; Wei XZ; Wang H; Zhang M; Yang ZJ; Zhang CH
J Toxicol Environ Health A; 2019; 82(19):1019-1026. PubMed ID: 31739764
[TBL] [Abstract][Full Text] [Related]
4. miR-219-5p inhibits tau phosphorylation by targeting TTBK1 and GSK-3β in Alzheimer's disease.
Li J; Chen W; Yi Y; Tong Q
J Cell Biochem; 2019 Jun; 120(6):9936-9946. PubMed ID: 30556160
[TBL] [Abstract][Full Text] [Related]
5. LncRNA TTN-AS1/miR-134-5p/PAK3 axis regulates the radiosensitivity of human large intestine cancer cells through the P21 pathway and AKT/GSK-3β/β-catenin pathway.
Zuo Z; Ji S; He L; Zhang Y; Peng Z; Han J
Cell Biol Int; 2020 Nov; 44(11):2284-2292. PubMed ID: 32749739
[TBL] [Abstract][Full Text] [Related]
6. RNA Interference Silencing of Glycogen Synthase Kinase 3β Inhibites Tau Phosphorylation in Mice with Alzheimer Disease.
Bian H; Bian W; Lin X; Ma Z; Chen W; Pu Y
Neurochem Res; 2016 Sep; 41(9):2470-80. PubMed ID: 27255602
[TBL] [Abstract][Full Text] [Related]
7. NPD1 Enhances Autophagy and Reduces Hyperphosphorylated Tau and Amyloid-β42 by Inhibiting GSK3β Activation in N2a/APP695swe Cells.
Dai S; Zhou F; Sun J; Li Y
J Alzheimers Dis; 2021; 84(2):869-881. PubMed ID: 34602482
[TBL] [Abstract][Full Text] [Related]
8. MiR-539-5p Decreases amyloid β-protein production, hyperphosphorylation of Tau and Memory Impairment by Regulating PI3K/Akt/GSK-3β Pathways in APP/PS1 Double Transgenic Mice.
Jiang Y; Zhang Y; Su L
Neurotox Res; 2020 Aug; 38(2):524-535. PubMed ID: 32415525
[TBL] [Abstract][Full Text] [Related]
9. LncRNA FOXD3-AS1 aggravates myocardial ischemia/reperfusion injury by inactivating the Redd1/AKT/GSK3β/Nrf2 signaling pathway via the miR-128/TXNIP axis.
Chen B; Zheng L; Zhu T; Jiao K
J Biochem Mol Toxicol; 2022 Dec; 36(12):e23218. PubMed ID: 36098178
[TBL] [Abstract][Full Text] [Related]
10. Long noncoding RNA SATB1-AS1 contributes to the chemotherapy resistance through the microRNA-580/ 2'-5'-oligoadenylate synthetase 2 axis in acute myeloid leukemia.
Zhou H; Jia X; Yang F; Shi P
Bioengineered; 2021 Dec; 12(1):6403-6417. PubMed ID: 34516354
[TBL] [Abstract][Full Text] [Related]
11. Circulatory GSK-3β: Blood-Based Biomarker and Therapeutic Target for Alzheimer's Disease.
Kumari S; Singh A; Singh AK; Yadav Y; Bajpai S; Kumar P; Upadhyay AD; Shekhar S; Dwivedi S; Dey AB; Dey S
J Alzheimers Dis; 2022; 85(1):249-260. PubMed ID: 34776454
[TBL] [Abstract][Full Text] [Related]
12. Tau phosphorylation by glycogen synthase kinase 3β modulates enzyme acetylcholinesterase expression.
Cortés-Gómez MÁ; Llorens-Álvarez E; Alom J; Del Ser T; Avila J; Sáez-Valero J; García-Ayllón MS
J Neurochem; 2021 Jun; 157(6):2091-2105. PubMed ID: 32955735
[TBL] [Abstract][Full Text] [Related]
13. BMSCs-exosomes containing GDF-15 alleviated SH-SY5Y cell injury model of Alzheimer's disease via AKT/GSK-3β/β-catenin.
Xiong WP; Yao WQ; Wang B; Liu K
Brain Res Bull; 2021 Dec; 177():92-102. PubMed ID: 34536520
[TBL] [Abstract][Full Text] [Related]
14. NEAT1 regulates microtubule stabilization via FZD3/GSK3β/P-tau pathway in SH-SY5Y cells and APP/PS1 mice.
Zhao Y; Wang Z; Mao Y; Li B; Zhu Y; Zhang S; Wang S; Jiang Y; Xu N; Xie Y; Xie W; Zhang Y
Aging (Albany NY); 2020 Nov; 12(22):23233-23250. PubMed ID: 33221742
[TBL] [Abstract][Full Text] [Related]
15. Long noncoding RNA OIP5-AS1 targets Wnt-7b to affect glioma progression via modulation of miR-410.
Sun WL; Kang T; Wang YY; Sun JP; Li C; Liu HJ; Yang Y; Jiao BH
Biosci Rep; 2019 Jan; 39(1):. PubMed ID: 30498093
[TBL] [Abstract][Full Text] [Related]
16. Neuroprotection and Mechanism of Gas-miR36-5p from
Lu Z; Fu J; Wu G; Yang Z; Wu X; Wang D; You Z; Nie Z; Sheng Q
Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139125
[TBL] [Abstract][Full Text] [Related]
17. Modulation of tau phosphorylation by the kinase PKR: implications in Alzheimer's disease.
Bose A; Mouton-Liger F; Paquet C; Mazot P; Vigny M; Gray F; Hugon J
Brain Pathol; 2011 Mar; 21(2):189-200. PubMed ID: 21029237
[TBL] [Abstract][Full Text] [Related]
18. Diabetes mellitus and Alzheimer's disease: GSK-3β as a potential link.
Zhang Y; Huang NQ; Yan F; Jin H; Zhou SY; Shi JS; Jin F
Behav Brain Res; 2018 Feb; 339():57-65. PubMed ID: 29158110
[TBL] [Abstract][Full Text] [Related]
19. FLZ alleviates the memory deficits in transgenic mouse model of Alzheimer's disease via decreasing beta-amyloid production and tau hyperphosphorylation.
Bao XQ; Li N; Wang T; Kong XC; Tai WJ; Sun H; Zhang D
PLoS One; 2013; 8(11):e78033. PubMed ID: 24223757
[TBL] [Abstract][Full Text] [Related]
20. A Unique GSK-3β inhibitor B10 Has a Direct Effect on Aβ, Targets Tau and Metal Dyshomeostasis, and Promotes Neuronal Neurite Outgrowth.
Shi XL; Yan N; Cui YJ; Liu ZP
Cells; 2020 Mar; 9(3):. PubMed ID: 32155989
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
